NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Jiangsu Biosurf Biotech Co., Ltd.

Jiangsu Biosurf Biotech Co., Ltd.

Private
SuzhouHealthcare & Life Scienceshttp://biosurf.cn/

Last Round

Series C

Jul 28, 2025

Total Funding Raised

$15.5M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Jiangsu Biosurf Biotech Co., Ltd. is a medical device and equipment company that provides a full-service platform for functional medical coatings, including materials, equipment, and testing services.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials, Biotech Equipment, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

medical device coatingsfunctional coatingshydrophilic coatinganticoagulant coatingantibacterial coatingsurface modificationbiomaterialscoating servicescoating equipmentcoating ODMlubricious coatingantithrombogenic coatingphosphorylcholine coatingmedical device componentscoated guidewireslow adhesion consumables

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Jiangsu Biosurf Biotech Co., Ltd. Comparables

Compare Jiangsu Biosurf Biotech Co., Ltd. with similar companies based on industry and business-model similarity.

Jiangsu Biosurf Biotech Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Harland Medical Systems
86%
Hydromer Inc.
80%
Formacoat
79%

Jiangsu Biosurf Biotech Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJul 28, 2025
Series B ExtensionAug 15, 2022
Series BApr 15, 2022

Jiangsu Biosurf Biotech Co., Ltd. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2025

    Led by Jolmo Investment

  • Aug 15, 2022

    Oriza Holdings led the Series B Extension round.

Jiangsu Biosurf Biotech Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Jiangsu Biosurf Biotech Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Jiangsu Biosurf Biotech Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSuzhou
Year Founded2017
Last FundingJul 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.